Roche posts higher sales on growth scross pharma, diagnostics units
Roche reiterated its full-year guidance and said it is prepared to launch its giredestrant breast-cancer pill later this year.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.hindustantimes.com — the content belongs to Hindustan Times - World.
